Treatment-Resistant Hypertension Management Market is expected to See Incredible Growth by 2033

The global Treatment-Resistant Hypertension Management Market is predicted to generate a market value of US$ 43 Million in 2023 and a market value of US$ 159.41 Million by 2033, with a CAGR of 14% from 2023 to 2033. From 2018 to 2022, the market for Treatment-Resistant Hypertension Management grew at a CAGR of 11%.

The growing prevalence of hypertension globally, as well as the expanding number of patients with Treatment-Resistant Hypertension, are driving the market for Treatment-Resistant Hypertension management. According to the World Health Organisation, hypertension is the biggest cause of cardiovascular illness and mortality in the world, impacting more than 1 billion people. The prevalence of Treatment-Resistant Hypertension is estimated to be 10% to 30% of all hypertensive individuals.

Treatment-Resistant Hypertension is often managed with a combination of antihypertensive drugs, including diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs). Many patients with Treatment-Resistant Hypertension, on the other hand, do not respond well to these drugs and may require more severe treatment options.

One of the primary factors driving the growth of the treatment-resistant hypertension management market is the rising prevalence of hypertension. Hypertension, often known as high blood pressure, is a chronic medical disorder characterised by chronically excessive blood pressure in the arteries. Hypertension is a key risk factor for cardiovascular disorders like heart disease and stroke, which are important sources of morbidity and mortality around the world.

Major Players:

Major players in the market include companies such as Competition Deep Dive, Janssen Biotech, Quantum Genomics SA, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma, KBP Biosciences, Abbott, Kona Medical, Inc., Medtronic along with healthcare providers and technology companies among other global players.

Browse More Details@ https://www.futuremarketinsights.com/reports/Treatment-resistant-hypertension-management-market

Key Segments Profiled in the Treatment-Resistant Hypertension Management Industry Survey

Treatment:

  • Diuretic therapy
  • Combination therapy
  • Mineralocorticoid receptor antagonists

Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasoun...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic ...
Read more